Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Name: Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer
License: Public Domain

Alison Stopeck

ClinicalTrials.gov · Datasets · License: Public Domain

breast cancer female, locally advanced breast cancer, hormone receptor positive malignant neoplasm of breast

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 417545
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.